The DOI matches its Crossref record; 246 of the 246 references it cites were found in a registry or an index.
Depression and coronary heart disease: 2018 position paper of the ESC working group on coronary pathophysiology and microcirculation
Open accessAbstract
Major depression is a highly prevalent condition, affecting approximately 10% of the population. It is also a growing global problem, and has been consistently associated with increased risk of coronary heart disease (CHD). It is therefore not surprising that depression is highly comorbid with CHD, being two to three times more common among patients with CHD than in the general population. The prevalence of depression is 15–30% in patients with CHD, and is approximately twice as high in women than men, especially affecting young women in the aftermath of acute myocardial infarction (MI). Depression as a risk factor for CHD has been characterized from mild depressive symptoms to a clinical diagnosis of major depression. As defined by the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), clinical depression, or major depression, is characterized by depressed mood or anhedonia (loss of interest or pleasure) for at least 2 weeks accompanied by significant functional impairment and additional somatic or cognitive symptoms. Most epidemiological studies of depression and incidence of CHD have used depressive symptom scales, and have frequently demonstrated a dose–response pattern, with higher levels of depressive symptoms being associated with higher risk. The exact mechanisms linking depression to increased CHD risk are complex and multifactorial, and still incompletely understood. Although adverse lifestyle behaviours and traditional CHD risk factors, such as smoking and sedentary lifestyle, largely contribute to the risk, they do not explain it entirely. In CHD patients, depression is also associated with severity of functional impairment, lower adherence to therapy and lower participation in cardiac rehabilitation. Whether and to what extent these factors explain the relationship between depression and CHD deserves future study. The present paper summarizes key aspects in our current knowledge linking depression and CHD within the intersecting fields of neuroscience, cardiovascular physiology, and behavioural medicine, with the objective of bringing attention to this area and stimulating interdisciplinary research, clinical awareness, and improved care.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“There is an absence of treatment for patients who screen positive for depression and anxiety, as screening for depression and anxiety in patients with IHD combined with treatment are far from universally implemented [20].”
From Efficacy and cost-effectiveness of a therapist-assisted web-based intervention for depression and anxiety in patients with ischemic heart disease attending cardiac rehabilitation [eMindYourHeart trial]: a randomised controlled trial protocol (2021) · cites this paper as [20]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In people with cardiovascular diseases and stroke survivors, MDD is associated with increased health care costs and unplanned rehospitalizations23,25, an increased risk of atrial fibrillation and chest pain2, and a significant decrease in quality of life45,46.”
From Comorbidity between major depressive disorder and physical diseases: a comprehensive review of epidemiology, mechanisms and management (2023) · cites this paper as [2]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The Danish situation is not unique, as screening combined with treatment of patients’ distress is far from universally implemented [20].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817 · cited 1×
“Assessment of severity of depressive symptoms can be performed with the Hamilton Depression Scale, a reliable and valid measure of depressive symptoms based on a clinician interview.(231) A score of greater than 9 is indicative of moderate to severe depression.”
MethodKessler, R. C., Chiu, W. T., Demler, O., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.617 · Cited by 12,052
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,527
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Authors/Task Force Members:, Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Ž., Verschuren, M., Albus, C., Benlian, P., Boysen, G., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs092 · Cited by 8,490
2016 European Guidelines on cardiovascular disease prevention in clinical practice
Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., Cooney, M.-T., Corrà, U., Cosyns, B., Deaton, C., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw106 · Cited by 6,457
Self-citation2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P. F., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castellà, M., Diener, H., Heidbüchel, H., Hendriks, J., et al. (2016) · EP Europace · doi:10.1093/europace/euw295 · Cited by 6,438
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw210 · Cited by 6,418
Self-citationWhiteford, H. A., Degenhardt, L., Rehm, J., Baxter, A. J., Ferrari, A. J., Erskine, H. E., Charlson, F. J., Norman, R. E., Flaxman, A. D., Johns, N., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61611-6 · Cited by 6,006
A Meta-Analysis of Cytokines in Major Depression
Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanctôt, K. L. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.033 · Cited by 4,729
Research works printed but not linked: 5
- Bremner, 2005, Changes in brain volume in major depression, Depression: Mind and Body, 2, 38
- Lane, 1995, Brain Asymmetry, 271
- First, 1995, Structured Clinical Interview for DSMIV-Patient Edition (SCID-P)
- Beck, 1996, Manual for the Beck Depression Inventory-II
- Davis, 2016, Posttraumatic Stress Disorder: From Neurobiology to Treatment, 389
Cited by
Sorted by citations
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
Visseren, F. L. J., Mach, F., Smulders, Y. M., Carballo, D., Koskinas, K. C., Bäck, M., Benetos, A., Biffi, A., Boavida, J.-M., Capodanno, D., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab484 · Cited by 6,485
Virani, S. S., Newby, L. K., Arnold, S. V., Bittner, V., Brewer, L. C., Demeter, S. H., Dixon, D. L., Fearon, W. F., Hess, B., Johnson, H. M., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001168 · Cited by 1,598
Virani, S. S., Newby, L. K., Arnold, S. V., Bittner, V., Brewer, L. C., Demeter, S. H., Dixon, D. L., Fearon, W. F., Hess, B., Johnson, H. M., et al. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.04.003 · Cited by 596
Berk, M., Köhler‐Forsberg, O., Turner, M., Penninx, B. W. J. H., Wrobel, A., Firth, J., Loughman, A., Reavley, N. J., McGrath, J. J., Momen, N. C., et al. (2023) · World Psychiatry · doi:10.1002/wps.21110 · Cited by 336
Rao, A., Zecchin, R., Newton, P., Phillips, J., DiGiacomo, M., Denniss, A., & Hickman, L. (2020) · European Journal of Preventive Cardiology · doi:10.1177/2047487319871716 · Cited by 146
Muse, E. D., & Topol, E. J. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.02.002 · Cited by 50
Kaihara, T., Scherrenberg, M., Intan-Goey, V., Falter, M., Kindermans, H., Frederix, I., & Dendale, P. (2022) · European Heart Journal - Digital Health · doi:10.1093/ehjdh/ztac037 · Cited by 29
Pedersen, S. S., Andersen, C. M., Ahm, R., Skovbakke, S. J., Kok, R., Helmark, C., Wiil, U. K., Schmidt, T., Olsen, K. R., Hjelmborg, J., et al. (2021) · BMC Cardiovascular Disorders · doi:10.1186/s12872-020-01801-w · Cited by 24
Bendig, E., Bauereiß, N., Buntrock, C., Habibović, M., Ebert, D. D., & Baumeister, H. (2021) · Internet Interventions · doi:10.1016/j.invent.2021.100375 · Cited by 20
Wang, N., Zhu, S., Chen, S., Zou, J., Zeng, P., & Tan, S. (2025) · Reviews in the Neurosciences · doi:10.1515/revneuro-2024-0147 · Cited by 12
Metadata
- Authors
- Vaccarino, V., Badimon, L., Bremner, J. D., Cenko, E., Cubedo, J., Dorobantu, M., Duncker, D. J., Koller, A., Manfrini, O., Milicic, D., Padro, T., Pries, A. R., Quyyumi, A. A., Tousoulis, D., Trifunovic, D., Vasiljevic, Z., de Wit, C., Bugiardini, R., ESC Scientific Document Group Reviewers, Lancellotti, P., & Carneiro, A. V.
- Affiliations
- Emory University (US)
- Cardiovascular Program (ICCC), IR-Hospital de la Santa Creu i Sant Pau. CiberCV-Institute Carlos III. Autonomous University of Barcelona , C/ Sant Antoni Maria Claret, 167, 08025, Barcelona,
- University of Bologna (IT)
- Universitat Autònoma de Barcelona (ES)
- Cardiology Department, University of Medicine and Pharmacy ‘Carol Davila’ of Bucharest, Emergency Clinical Hospital of Bucharest , Calea Floreasca 8, Sector 1, Bucuresti, 014461,
- Erasmus MC (NL)
- Institute of Natural Sciences, University of Physical Education , Alkotas street, 44, 1123, Budapest,
- Department for Cardiovascular Diseases, University Hospital Center Zagreb, University of Zagreb , Kispaticeva 12, HR-10000, Zagreb,
- Charité – Universitätsmedizin Berlin (DE)
- National and Kapodistrian University of Athens (GR)
- Department of Cardiology, University Clinical Center of Serbia , Pasterova 2, 11000, Belgrade,
- School of Medicine, University of Belgrade , Dr Subotica 8, 11000, Belgrade,
- Institut für Physiologie, Universität zu Lübeck and Deutsches Zentrumfür Herz-Kreislauf-Forschung (DZHK) , Ratzeburger Allee 160, 23538, Lübeck,
- University of Liège (BE)
- University of Lisbon (PT)
- Corresponding author
- Bugiardini, Raffaele
- ORCID
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2019-01-28
- Volume
- 41
- Issue
- 17
- Pages
- 1687-1696
- ISSN
- 0195-668X (ISSN-L)
- 1522-9645
- PMC
- PMC10941327
- OpenAlex
- W2912703574
- Cited by
- 404
- References
- 246
- Citations by year
- 2026: 41 · 2025: 67 · 2024: 63 · 2023: 49 · 2022: 71 · 2021: 48 · 2020: 43 · 2019: 21
- FWCI
- 33.05
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- European Heart Journal (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- ORBi (University of Liège) (submittedVersion, other-oa)
- Touro Scholar (Touro College) (submittedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion, other-oa)
- Funders
- NIH
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Cardiac Imaging and Diagnostics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Rate Variability and Autonomic Control
- Keywords
- major depressive disorder, coronary artery disease, comorbidities, cardiovascular risk factors, depressive symptoms, myocardial infarction, cardiac rehabilitation, medication adherence, lifestyle habits, sex differences, microcirculation, anhedonia
- MeSH terms
- Coronary Circulation, Coronary Disease, Depression, Heart, Humans, Microcirculation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
